Induction of a major histocompatibility complex class I-restricted cytotoxic T-lymphocyte response to a highly conserved region of human immunodeficiency virus type 1 (HIV-1) gp120 in seronegative humans immunized with a candidate HIV-1 vaccine
about
Design and pre-clinical evaluation of a universal HIV-1 vaccineHigh major histocompatibility complex-unrestricted lysis of simian immunodeficiency virus envelope-expressing cells predisposes macaques to rapid AIDS progressionT-cell receptor-mediated anergy of a human immunodeficiency virus (HIV) gp120-specific CD4(+) cytotoxic T-cell clone, induced by a natural HIV type 1 variant peptide.Relative dominance of epitope-specific cytotoxic T-lymphocyte responses in human immunodeficiency virus type 1-infected persons with shared HLA allelesLimited sequence evolution within persistently targeted CD8 epitopes in chronic human immunodeficiency virus type 1 infection.Early induction and maintenance of Env-specific T-helper cells following human immunodeficiency virus type 1 infectionLimited breadth of a T-helper cell response to a human immunodeficiency virus envelope protein.Efficient lysis of human immunodeficiency virus type 1-infected cells by cytotoxic T lymphocytes.Analysis of the human env-specific cytotoxic T-lymphocyte (CTL) response in natural human immunodeficiency virus type 1 infection: low prevalence of broadly cross-reactive env-specific CTL.Active immunotherapy of cancer with a nonreplicating recombinant fowlpox virus encoding a model tumor-associated antigen.Cytokine enhancement of DNA immunization leads to effective treatment of established pulmonary metastases.Frequency of HLA allele-specific peptide motifs in HIV-1 proteins correlates with the allele's association with relative rates of disease progression after HIV-1 infection.A simian immunodeficiency virus envelope V3 cytotoxic T-lymphocyte epitope in rhesus monkeys and its restricting major histocompatibility complex class I molecule Mamu-A*02.Safety and Immunogenicity of a Randomized Phase 1 Prime-Boost Trial With ALVAC-HIV (vCP205) and Oligomeric Glycoprotein 160 From HIV-1 Strains MN and LAI-2 Adjuvanted in Alum or PolyphosphazeneIdentification of type-specific cytotoxic T lymphocyte responses to homologous viral proteins in laboratory workers accidentally infected with HIV-1.Impact of a single HLA-A*24:02-associated escape mutation on the detrimental effect of HLA-B*35:01 in HIV-1 control
P2860
Q21092234-DC35278E-85BA-468D-B220-C3BE5C11031CQ33646313-29C5ED76-D527-4A3C-8A1F-4605C117480FQ33798409-96294584-4B45-429D-99DA-A826E953B1C0Q33842771-B990DFED-AB1D-4832-9C4A-4B43F9C29DC4Q33843340-63A8F257-DD8B-435F-82A2-DC839F1D2280Q34470969-A29D6BD0-F174-472D-8ECD-DDDC369D92F7Q34781685-838AB11F-7230-4820-B670-02871CBB699EQ35867686-815F331C-C231-469A-B473-1BA5E3DD8ADDQ35873361-09136596-510C-451A-8B22-6DB8C61559B2Q35990356-0C309683-8467-485C-BC2F-FA3FDEC21295Q36088999-4D5D6EE2-F273-4BB2-BC23-1C34388C48A6Q36575290-8C1E5183-020C-490C-B224-90106BA5BBE4Q36636482-4D05C65B-F9DC-4AE4-902E-62A47D82AE51Q36931790-5CA683B7-1875-4332-AED5-9B6DC7C9BF13Q37363548-125DD0F7-A668-49CF-8339-E5549D0A18E2Q58702145-E7B6D7EE-F1FD-489A-BE3B-3E4F2BD304E1
P2860
Induction of a major histocompatibility complex class I-restricted cytotoxic T-lymphocyte response to a highly conserved region of human immunodeficiency virus type 1 (HIV-1) gp120 in seronegative humans immunized with a candidate HIV-1 vaccine
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Induction of a major histocomp ...... with a candidate HIV-1 vaccine
@ast
Induction of a major histocomp ...... with a candidate HIV-1 vaccine
@en
type
label
Induction of a major histocomp ...... with a candidate HIV-1 vaccine
@ast
Induction of a major histocomp ...... with a candidate HIV-1 vaccine
@en
prefLabel
Induction of a major histocomp ...... with a candidate HIV-1 vaccine
@ast
Induction of a major histocomp ...... with a candidate HIV-1 vaccine
@en
P2093
P2860
P1433
P1476
Induction of a major histocomp ...... with a candidate HIV-1 vaccine
@en
P2093
B D Walker
R F Siliciano
R P Johnson
S A Hammond
P2860
P304
P407
P577
1994-05-01T00:00:00Z